RAJNISH WELLNESS
|
RAJNISH WELLNESS Last 5 Year Financial Ratios History
[Standalone]
| Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 0.01 | 0.01 | 0.37 | 0.21 | -1.30 |
| CEPS(Rs) | 0.01 | 0.01 | 0.01 | - | -0.02 |
| DPS(Rs) | - | - | - | - | - |
| Book NAV/Share(Rs) | 1.09 | 1.08 | 21.04 | 46.49 | 46.28 |
| Tax Rate(%) | 28.53 | 27.25 | 28.58 | 13.68 | 1.31 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 2.60 | -4.30 | -0.36 | -23.73 | 0.98 |
| EBIT Margin(%) | 2.57 | 2.59 | 3.15 | 3.14 | 1.98 |
| Pre Tax Margin(%) | 1.89 | 2.45 | 2.08 | 0.87 | -4.49 |
| PAT Margin (%) | 1.35 | 1.78 | 1.48 | 0.75 | -4.43 |
| Cash Profit Margin (%) | 1.38 | 1.83 | 1.51 | 1.16 | -4.04 |
| Performance Ratios | |||||
| ROA(%) | 1.01 | 0.69 | 1.13 | 0.29 | -1.88 |
| ROE(%) | 1.24 | 0.88 | 1.79 | 0.46 | -2.78 |
| ROCE(%) | 2.17 | 1.08 | 2.71 | 1.40 | 0.97 |
| Asset Turnover(x) | 0.75 | 0.39 | 0.76 | 0.39 | 0.42 |
| Sales/Fixed Asset(x) | 236.32 | 89.27 | 102.07 | 54.60 | 56.54 |
| Working Capital/Sales(x) | 1.19 | 0.81 | 0.93 | 0.50 | 0.52 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | - | 0.01 | 0.01 | 0.02 | 0.02 |
| Receivable days | 128.14 | 257.12 | 227.79 | 393.83 | 407.72 |
| Inventory Days | 30.97 | 41.29 | 22.06 | 29.23 | 52.81 |
| Payable days | 47.74 | 36.48 | 24.50 | 39.84 | 51.68 |
| Valuation Parameters | |||||
| PER(x) | 484.33 | 2,766.67 | 7.50 | 0.78 | - |
| PCE(x) | 471.71 | 2,699.26 | 221.43 | 33.86 | -15.68 |
| Price/Book(x) | 5.95 | 15.40 | 3.99 | 0.24 | 0.40 |
| Yield(%) | - | - | - | - | - |
| EV/Net Sales(x) | 6.56 | 49.78 | 3.64 | 1.03 | 1.19 |
| EV/Core EBITDA(x) | 252.50 | 1,884.64 | 114.66 | 28.90 | 50.30 |
| EV/EBIT(x) | 255.59 | 1,919.82 | 115.51 | 32.73 | 60.09 |
| EV/CE(x) | 5.67 | 13.82 | 2.75 | 0.40 | 0.49 |
| M Cap / Sales | 6.50 | 49.39 | 3.34 | 0.39 | 0.63 |
| Growth Ratio | |||||
| Net Sales Growth(%) | 196.93 | -2.31 | 98.16 | -2.95 | -67.01 |
| Core EBITDA Growth(%) | 192.30 | -18.76 | 76.80 | 46.14 | -95.23 |
| EBIT Growth(%) | 194.16 | -19.65 | 98.76 | 54.14 | -95.97 |
| PAT Growth(%) | 124.56 | 17.37 | 293.18 | 116.38 | -114.37 |
| EPS Growth(%) | 123.33 | -98.39 | 74.75 | 116.38 | -114.37 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | 0.06 | 0.12 | 0.41 | 0.40 | 0.36 |
| Current Ratio(x) | 4.86 | 6.58 | 5.81 | 4.90 | 5.48 |
| Quick Ratio(x) | 4.30 | 5.92 | 5.46 | 4.74 | 5.30 |
| Interest Cover(x) | 3.76 | 18.00 | 2.93 | 1.38 | 0.31 |
| Total Debt/Mcap(x) | 0.01 | 0.01 | 0.10 | 1.64 | 0.88 |
Compare Financial Ratios of peers of RAJNISH WELLNESS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| RAJNISH WELLNESS | ₹116.8 Cr | -2.6% | -18.2% | -87% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹441,838.0 Cr | 1% | 0.7% | 47.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹156,107.0 Cr | -1.1% | -5.8% | 61.7% | Stock Analytics | |
| CIPLA | ₹120,270.0 Cr | 0.3% | -1.8% | 19.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹113,077.0 Cr | 6% | 11.8% | 20.3% | Stock Analytics | |
| ZYDUS LIFESCIENCES | ₹96,553.2 Cr | -1.5% | -0.1% | 47% | Stock Analytics | |
RAJNISH WELLNESS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| RAJNISH WELLNESS | -2.6% |
-18.2% |
-87% |
| SENSEX | -2.1% |
-2% |
11.3% |
You may also like the below Video Courses
